World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02238288
Date of registration: 10/09/2014
Prospective Registration: No
Primary sponsor: Grupo de Estudos Multicentricos em Onco-Hematologia
Public title: Randomized Clinical Trial With Aminocaproic Acid in the Prevention of Exodontic Bleeding in Anticoagulants Patients
Scientific title: Randomized Clinical Trial to Verify the Effectiveness of Topical Aminocaproic Acid in the Prevention of Post-exodontic Bleeding in Patients on Anticoagulants
Date of first enrolment: December 2013
Target sample size: 154
Recruitment status: Enrolling by invitation
URL:  http://clinicaltrials.gov/show/NCT02238288
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention  
Phase:  Phase 4
Countries of recruitment
Brazil
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients over 18 years of age, use of warfarin sodium with or without anti-platelet
aggregation, indicating simple extractions whose INR values ??are between 2.0 and 4.0
and that consent to participate in the study.

Exclusion Criteria:

- Patients with platelet count < 50,000 / mm3 Pregnant women or lactating Patients with
hypersensitivity to the components of EACA. Patients with coagulopathies Patients who
have impacted teeth, ankylosed or root morphological alterations that may complicate
the procedure Patients who fail to submit laboratory and radiographic examinations
necessary for the surgery



Age minimum: N/A
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Oral Hemorrhage
Intervention(s)
Drug: Paracetamol
Drug: lidocaine and epinephrine
Other: Routine dental care
Drug: Aminocaproic acid
Primary Outcome(s)
bleeding post-exodontic [Time Frame: up to twenty minutes]
Secondary Outcome(s)
Secondary ID(s)
AEAC2014
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history